Morgan Stanley Maintains Equal-Weight on ArcBest, Lowers Price Target to $35

Morgan Stanley analyst Ravi Shanker maintains ArcBest (NASDAQ:ARCB) with a Equal-Weight and lowers the price target from $36 to $35.

Benzinga · 01/06/2020 14:07

Morgan Stanley analyst Ravi Shanker maintains ArcBest (NASDAQ:ARCB) with a Equal-Weight and lowers the price target from $36 to $35.